For example, work in my research group has recently described the development of highly potent anti-tumor natural killer (NK) cells derived from hESCs that can be utilized to treat conditions such as cancer and HIV. Other hESC-based therapies for cardiac disease, diabetes, Parkinson???s disease, blindness due to macular degeneration, and other diseases with no current curative options are imminent